المؤلفون: GENERALI, DANIELE, SCHIRONE, ALICE, COGNETTI, FRANCESCA, NUZZO, FEDERICA, Montemurro, F., Bordonaro, R., Mafodda, A., Romito, S., Michelotti, A., Piovano, P., Ionta, M. T., Bighin, C., Sartori, D., Frassoldati, A., Cazzaniga, M. E., Riccardi, F., Testore, F., Vici, P., Barone, C. A. ., Piacentini, F., Nolè, F., Molino, A., Latini, L., Simoncini, E. L., Roila, F., Foglietta, J., Minisini, A. M., Goffredo, F., Portera, G., Ascione, G., Mariani, G.

المساهمون: Generali, Daniele, Montemurro, F., Bordonaro, R., Mafodda, A., Romito, S., Michelotti, A., Piovano, P., Ionta, M. T., Bighin, C., Sartori, D., Frassoldati, A., Cazzaniga, M. E., Riccardi, F., Testore, F., Vici, P., Barone, C. A. ., Schirone, Alice, Piacentini, F., Nolè, F., Molino, A., Latini, L., Simoncini, E. L., Roila, F., Cognetti, Francesca, Nuzzo, Federica, Foglietta, J., Minisini, A. M., Goffredo, F., Portera, G., Ascione, G., Mariani, G.

مصطلحات موضوعية: Advanced breast cancer, Everolimu, Hormone‐receptor positive, Real life, Safety

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28432226; info:eu-repo/semantics/altIdentifier/wos/WOS:000403210700006; volume:22; issue:6; firstpage:648; lastpage:654; numberofpages:7; journal:THE ONCOLOGIST; http://hdl.handle.net/11368/2903506Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85020872203; http://theoncologist.alphamedpress.org/content/early/2017/04/07/theoncologist.2016-0461.longTest

الإتاحة: https://doi.org/10.1634/theoncologist.2016-0461Test
http://hdl.handle.net/11368/2903506Test
http://theoncologist.alphamedpress.org/content/early/2017/04/07/theoncologist.2016-0461.longTest

المؤلفون: Malorni, L., Curigliano, G., Minisini, A. M., Cinieri, S., Tondini, C. A., D'Hollander, K., Arpino, G., Bernardo, A., Martignetti, A., Criscitiello, C., Puglisi, F., Pestrin, M., Sanna, G., Moretti, E., Risi, E., Biagioni, C., McCartney, A., Boni, L., Buyse, M., Migliaccio, I., Biganzoli, L., Di Leo, A.

المساهمون: L. Malorni, G. Curigliano, A.M. Minisini, S. Cinieri, C.A. Tondini, K. D'Hollander, G. Arpino, A. Bernardo, A. Martignetti, C. Criscitiello, F. Puglisi, M. Pestrin, G. Sanna, E. Moretti, E. Risi, C. Biagioni, A. Mccartney, L. Boni, M. Buyse, I. Migliaccio, L. Biganzoli, A. Di Leo

مصطلحات موضوعية: Advanced breast cancer, CDK4/6 inhibitor, Endocrine resistance, Palbociclib, Hematology, Oncology, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29893790; info:eu-repo/semantics/altIdentifier/wos/WOS:000442277600021; volume:29; issue:8; firstpage:1748; lastpage:1754; numberofpages:7; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/2434/623223Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85053871122

الإتاحة: https://doi.org/10.1093/annonc/mdy214Test
http://hdl.handle.net/2434/623223Test

المؤلفون: Generali D, Montemurro F, Bordonaro R, Mafodda A, Romito S, Michelotti A, Piovano P, Ionta MT, Bighin C, Sartori D, Frassoldati A, Cazzaniga ME, Riccardi F, Testore F, Vici P, Barone CA, Schirone A, Piacentini F, Nolè F, Molino A, Latini L, Simoncini EL, Roila F, Cognetti F, Nuzzo F, Foglietta J, Minisini AM, Goffredo F, Portera G, Ascione G, Mariani G, Cazzaniga M, contributor

المساهمون: Generali, D, Montemurro, F, Bordonaro, R, Mafodda, A, Romito, S, Michelotti, A, Piovano, P, Ionta, M, Bighin, C, Sartori, D, Frassoldati, A, Cazzaniga, M, Riccardi, F, Testore, F, Vici, P, Barone, C, Schirone, A, Piacentini, F, Nolè, F, Molino, A, Latini, L, Simoncini, E, Roila, F, Cognetti, F, Nuzzo, F, Foglietta, J, Minisini, A, Goffredo, F, Portera, G, Ascione, G, Mariani, G, Contributor, Generali, Daniele, Montemurro, F., Bordonaro, R., Mafodda, A., Romito, S., Michelotti, A., Piovano, P., Ionta, M. T., Bighin, C., Sartori, D., Frassoldati, A., Cazzaniga, M. E., Riccardi, F., Testore, F., Vici, P., Barone, C. A. ., Schirone, Alice, Piacentini, F., Nolè, F., Molino, A., Latini, L., Simoncini, E. L., Roila, F., Cognetti, Francesca, Nuzzo, Federica, Foglietta, J., Minisini, A. M., Goffredo, F., Portera, G., Ascione, G., Mariani, G.

المصدر: The oncologist. 22(6)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Advanced breast cancer, Everolimus, Hormone-receptor positive, Real life, Safety, medicine.medical_treatment, chemistry.chemical_compound, 0302 clinical medicine, Exemestane, Antineoplastic Combined Chemotherapy Protocols, Medicine, Neoplasm Metastasis, Aged, 80 and over, advanced breast cancer, everolimus, hormone-receptor positive, real life, safety, Middle Aged, Metastatic breast cancer, Everolimu, Italy, 030220 oncology & carcinogenesis, Female, medicine.drug, Hormone‐receptor positive, Adult, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Socio-culturale, Breast Neoplasms, Everolimus Plus Exemestane, Advanced Breast Cancer, BALLET Study, 03 medical and health sciences, Breast cancer, Internal medicine, Post-hoc analysis, Breast Cancer, Humans, Adverse effect, Aged, Chemotherapy, business.industry, medicine.disease, Androstadienes, Regimen, 030104 developmental biology, chemistry, business

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b87282dd1bb2428ee2818fcd5b96181Test
https://pubmed.ncbi.nlm.nih.gov/28432226Test